Research on COVID-19 – BiR-nCov19 Drug Development Team

On the 31st of March 2020, Bioinformatics Review created a team of bioinformatics researchers from all over the world to find potential drug candidates for nCov-19. This group is a collaborative effort and works remotely from all over the world. This group has 150+ researchers from 21 Countries.

 

Updates

Read about our latest selection pressure study on spike glycoproteins of SARS-CoV.

Update: Selection analysis on spike glycoproteins of SARS-CoV

Read about our latest selection pressure study on spike glycoproteins of SARS-CoV-2.

Update: Selection analysis on spike glycoprotein of SARS-CoV-2

Read about our latest work on phylogenetics analysis of spike glycoproteins of SARS-CoV-2 and SARS-CoV.

Phylogenetics analysis of SARS-CoV-2 spike glycoproteins

 

Data

Find all the necessary files here.

Fig. 1 Phylogenetic tree of SARS-CoV-2 spike sequences with SARS-CoV spike sequences as an outgroup.

Fig. 2 MSA of all spike glycoprotein sequences of SARS-CoV-2 and SARS-CoV.

File 1 MSA of all spike glycoprotein sequences of SARS-CoV-2 and SARS-CoV showing conserved residues.

Fig. 3 Structure of Spike Glycoprotein (PDB ID: 6VXX) of SARS-CoV-2. The detected residues under positive selection are shown in red color.

Willing to stay updated?

By investing less than 30 seconds you can start recieving all our new articles in your mailbox. Stay updated with latest Bioinformatics Research, trends and tools of trade.

 

Lost your password? Please enter your email address. You will receive mail with link to set new password.

Help-Desk